ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.5917+5G>A

dbSNP: rs1555395743
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Centre of Medical Genetics, University of Antwerp RCV002246043 SCV002025372 uncertain significance Marfan syndrome 2021-03-01 criteria provided, single submitter research PM2, PM8, PP4
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV002246043 SCV005398558 likely pathogenic Marfan syndrome 2020-10-19 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Likely pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with FBN1-related disease. Variants predicted to result in nonsense mediated decay cause loss of function effects, and are more commonly associated with severe Marfan syndrome (MIM#154700). Missense variants with both dominant negative and loss of function effects on protein function, are also associated with causing Marfan syndrome and additionally, ectopia lentis (MIM#129600) (OMIM, PMID: 29357934). The exact genotype-phenotype correlation for this gene is still unclear, and is compounded by variable expressivity (GeneReviews). (I) 0108 - This gene is associated with both recessive and dominant disease. Patients with a recessive form of disease have Marfan syndrome, however there are very few reports (OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity. The genotype-phenotype correlations for this gene are unclear, with single variants reported in patients with a range of phenotypes (GeneReviews, OMIM). (I) 0212 - Non-canonical splice site variant without proven consequence on splicing (no functional evidence available). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0505 - Abnormal splicing predictions by in silico tools are conflicting but affected nucleotide is highly conserved. (I) 0710 - Another splice variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. A splice variant at the same nucleotide position (c.5917+5G>T) has been reported as a VUS in a patient with Marfan syndrome (ClinVar). (I) 0802 - This variant has moderate previous evidence of pathogenicity in an unrelated individual. This variant has been classified as pathogenic and reported in a patient with Marfan syndrome (PMID: 11826022), and a de novo patient with cardiac defects, ectopia lentis and arachnodactyly (Decipher). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed) (VCGS #18G003425, 18G004342). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.